O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-15.33%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.89B
AUM Growth
+$9.89B
(-16%)
Cap. Flow
+$87.5M
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
40.11%
Holding
146
New
15
Increased
26
Reduced
29
Closed
10
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$107M |
| 2 |
Eli Lilly
LLY
|
$106M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
$98M |
| 4 |
HCA Healthcare
HCA
|
$63.5M |
| 5 |
Dynavax Technologies
DVAX
|
$60.7M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$161M |
| 2 |
SHPG
Shire pic
SHPG
|
$132M |
| 3 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$120M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$119M |
| 5 |
Gilead Sciences
GILD
|
$69.8M |
Sector Composition
| 1 | Healthcare | 92.21% |
| 2 | Financials | 0.24% |
| 3 | Technology | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Agilent Technologies
A
$35.5B
| $121M | 1.23% |
3,539,000
-129,000
| -4% | -$4.43M |
|
27
Pfizer
PFE
$141B
| $118M | 1.19% |
3,763,000
+710,000
| +23% | +$22.3M |
|
28
Ironwood Pharmaceuticals
IRWD
$201M
| $117M | 1.18% |
11,226,400
-1,176,100
| -9% | -$12.3M |
|
29
Community Health Systems
CYH
$392M
| $116M | 1.17% |
2,720,200
+1,190,200
| +78% | +$50.9M |
|
|
INSY
30
DELISTED
Insys Therapeutics, Inc.
INSY
| $116M | 1.17% |
4,081,800
+1,458,800
| +56% | +$41.5M |
|
31
Intuitive Surgical
ISRG
$158B
| $110M | 1.11% |
239,000
-62,300
| -21% | -$28.6M |
|
|
ESRX
32
DELISTED
Express Scripts Holding Company
ESRX
| $109M | 1.1% |
1,342,000
| – | – |
|
|
33
Eli Lilly
LLY
$661B
| $106M | 1.07% |
+1,272,000
| New | +$106M |
|
|
BLUE
34
DELISTED
bluebird bio
BLUE
| $102M | 1.03% |
1,188,900
+230,600
| +24% | +$19.7M |
|
|
CLVS
35
DELISTED
Clovis Oncology, Inc.
CLVS
| $102M | 1.03% |
1,105,900
+100,700
| +10% | +$9.26M |
|
|
MGLN
36
DELISTED
Magellan Health Services, Inc.
MGLN
| $102M | 1.03% |
1,833,000
+382,300
| +26% | +$21.2M |
|
|
AGN.PRA
37
DELISTED
Allergan plc.
AGN.PRA
| $98.3M | 0.99% |
104,200
| – | – |
|
38
Puma Biotechnology
PBYI
$258M
| $90.1M | 0.91% |
1,195,500
+254,700
| +27% | +$19.2M |
|
|
ISEE
39
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $77.9M | 0.79% |
1,923,500
+248,900
| +15% | +$10.1M |
|
|
MNK
40
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $75M | 0.76% |
1,173,000
+378,000
| +48% | +$24.2M |
|
|
NUVA
41
DELISTED
NuVasive, Inc.
NUVA
| $71.7M | 0.72% |
1,487,000
| – | – |
|
42
Glaukos
GKOS
$5.42B
| $70.1M | 0.71% |
2,897,937
| – | – |
|
|
TSRO
43
DELISTED
TESARO, Inc.
TSRO
| $69.6M | 0.7% |
1,735,200
-336,280
| -16% | -$13.5M |
|
|
AFFX
44
DELISTED
AFFYMETRIX INC
AFFX
| $64.1M | 0.65% |
7,511,000
| – | – |
|
|
45
Dynavax Technologies
DVAX
$1.19B
| $60.7M | 0.61% |
+2,472,200
| New | +$60.7M |
|
46
Insmed
INSM
$30.3B
| $58.4M | 0.59% |
3,145,301
+1,436,801
| +84% | +$26.7M |
|
|
ARRY
47
DELISTED
Array Biopharma Inc
ARRY
| $45.9M | 0.46% |
10,060,500
| – | – |
|
|
PTLA
48
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $42M | 0.42% |
984,700
+134,000
| +16% | +$5.71M |
|
|
SRRA
49
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $40.8M | 0.41% |
+1,989,949
| New | +$40.8M |
|
|
OTIC
50
DELISTED
Otonomy, Inc.
OTIC
| $40.2M | 0.41% |
2,256,398
| – | – |
|